Literature DB >> 8450036

Metabolic handling of orally administered glucose in cirrhosis.

Y T Kruszynska1, A Meyer-Alber, F Darakhshan, P D Home, N McIntyre.   

Abstract

We used a dual-isotope method (oral [1-14C]glucose and intravenous [6-3H]glucose) to examine whether the oral glucose intolerance of cirrhosis is due to (a) a greater input of glucose into the systemic circulation (owing to a lower first-pass hepatic uptake of ingested glucose, or to impaired inhibition of hepatic glucose output), (b) a lower rate of glucose removal, or (c) a combination of these mechanisms. Indirect calorimetry was used to measure oxidative and nonoxidative metabolism. Basal plasma glucose levels (cirrhotics, 5.6 +/- 0.4[SE], controls, 5.1 +/- 0.2 mmol/liter), and rates of glucose appearance (Ra) and disappearance (Rd) were similar in the two groups. After 75 g of oral glucose, plasma glucose levels were higher in cirrhotics than controls, the curves diverging for 80 min despite markedly higher insulin levels in cirrhotics. During the first 20 min, there was very little change in glucose Rd and the greater initial increase in plasma glucose in cirrhotics resulted from a higher Ra of ingested [1-14C]glucose into the systemic circulation, suggesting a reduced first-pass hepatic uptake of portal venous glucose. The continuing divergence of the plasma glucose curves was due to a lower glucose Rd between 30 and 80 min (cirrhotics 236 +/- 17 mg/kg in 50 min, controls 280 +/- 17 mg/kg in 50 min, P < 0.05, one-tailed test). Glucose metabolic clearance rate rose more slowly in cirrhotics and was significantly lower than in controls during the first 2 h after glucose ingestion (2.24 +/- 0.17 vs 3.30 +/- 0.23 ml/kg per min, P < 0.005), in keeping with their known insulin insensitivity. Despite the higher initial glucose Ra in cirrhotics, during the entire 4-h period the quantity of total glucose and of ingested glucose (cirrhotics 54 +/- 2 g [72% of oral load], controls 54 +/- 3 g) appearing in the systemic circulation were similar. Overall glucose Rd (cirrhotics 72.5 +/- 3.8 g/4 h, controls 77.2 +/- 2.2 g/4h) and percent suppression of hepatic glucose output over 4 h (cirrhotics, 53 +/- 10%, controls 49 +/- 8%) were also similar. After glucose ingestion much of the extra glucose utilized was oxidized to provide energy that in the basal state was derived from lipid fuels. Glucose oxidation after glucose ingestion was similar in both groups and accounted for approximately two-thirds of glucose Rd. The reduction in overall nonoxidative glucose disposal did not reach significance (21 +/- 5 vs. 29 +/- 3 g/4 h, 0.05 < P < 0.1). Although our data would be compatible with an impairment of tissue glycogen deposition after oral glucose, glucose storage as glycogen probably plays a small part part in overall glucose disposal. Our results suggest that the higher glucose levels seen in cirrhotics after oral glucose are due initially to an increase in the amount of ingested glucose appearing in the systemic circulation, and subsequently to an impairment in glucose uptake by tissues due to insulin insensitivity. Impaired suppression of hepatic glucose output does not contribute to oral glucose intolerance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450036      PMCID: PMC288060          DOI: 10.1172/JCI116263

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  SMALL INTESTINAL GLUCOSE, ELECTROLYTE, AND WATER ABSORPTION IN CIRRHOSIS.

Authors:  R B TALLEY; H P SCHEDL; J A CLIFTON
Journal:  Gastroenterology       Date:  1964-10       Impact factor: 22.682

2.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

3.  Influences of glucose loading and of injected insulin on hepatic glucose output.

Authors:  R STEELE
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

4.  The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state; measurements of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm.

Authors:  R ANDRES; G CADER; K L ZIERLER
Journal:  J Clin Invest       Date:  1956-06       Impact factor: 14.808

5.  Glucose tolerance and diabetes in chronic liver disease.

Authors:  C Megyesi; E Samols; V Marks
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

6.  The role of the portal circulation in glucose and fructose tolerance.

Authors:  N McIntyre; D S Turner; C D Holdsworth
Journal:  Diabetologia       Date:  1970-12       Impact factor: 10.122

7.  Critical variables in the radioimmunoassay of serum insulin using the double antibody technic.

Authors:  J S Soeldner; D Slone
Journal:  Diabetes       Date:  1965-12       Impact factor: 9.461

8.  Metabolic consequences of portacaval shunting in the rat: effects on glucose tolerance and serum immunoreactive insulin response.

Authors:  J P Assal; R Levrat; W Stauffacher; A E Renold
Journal:  Metabolism       Date:  1971-09       Impact factor: 8.694

9.  Underestimation of hepatic glucose production by radioactive and stable tracers.

Authors:  G M Argoud; D S Schade; R P Eaton
Journal:  Am J Physiol       Date:  1987-05

10.  Cirrhosis and diabetes. II. Association of impaired glucose tolerance with portal-systemic shunting in Laennec's cirrhosis.

Authors:  H O Conn; W Schreiber; S G Elkington
Journal:  Am J Dig Dis       Date:  1971-03
View more
  7 in total

1.  Effects of collateral vessel occlusion on oral glucose tolerance test in liver cirrhosis.

Authors:  N Tanabe; M Ishii; Y Sato; T Akahane; N Kobayashi; H Gama; T Iwasaki; T Toyota
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

Review 2.  Metabolism of energy-yielding substrates in patients with liver cirrhosis.

Authors:  M J Müller; K H Böker; O Selberg
Journal:  Clin Investig       Date:  1994-08

3.  Hepatocytes of cirrhotic rat liver accumulate glycogen more slowly than normal ones.

Authors:  Natalia N Bezborodkina; Sergey V Okovity; Anna Yu Chestnova; Boris N Kudryavtsev
Journal:  Hepatol Int       Date:  2013-07-23       Impact factor: 6.047

4.  Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension.

Authors:  Tsuyoshi Ishikawa; Shogo Shiratsuki; Takashi Matsuda; Takuya Iwamoto; Taro Takami; Koichi Uchida; Shuji Terai; Takahiro Yamasaki; Isao Sakaida
Journal:  J Gastroenterol       Date:  2013-10-05       Impact factor: 7.527

5.  Postprandial Glycogen Content Is Increased in the Hepatocytes of Human and Rat Cirrhotic Liver.

Authors:  Natalia N Bezborodkina; Sergey V Okovityi; Boris N Kudryavtsev
Journal:  Cells       Date:  2021-04-21       Impact factor: 6.600

6.  Lack of the Lysosomal Membrane Protein, GLMP, in Mice Results in Metabolic Dysregulation in Liver.

Authors:  Xiang Yi Kong; Eili Tranheim Kase; Anette Herskedal; Camilla Schjalm; Markus Damme; Cecilie Kasi Nesset; G Hege Thoresen; Arild C Rustan; Winnie Eskild
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

7.  Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease.

Authors:  Shoko Kuriyama; Yoshiyuki Miwa; Hideki Fukushima; Hironori Nakamura; Katsuhisa Toda; Makoto Shiraki; Masahito Nagaki; Mayumi Yamamoto; Eiichi Tomita; Hisataka Moriwaki
Journal:  J Clin Biochem Nutr       Date:  2007-03       Impact factor: 3.114

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.